Meet our 2020 Speakers

Brian Abramson, Attorney and Treatise Author, Bloomberg Law

Brian Abramson | Attorney and Treatise Author | Bloomberg Law » speaking at Vaccine Congress USA

Margaret Ellen Ackerman, Associate Engineering Professor, Dartmouth College

Margaret Ellen Ackerman | Associate Engineering Professor | Dartmouth College » speaking at Vaccine Congress USA

Hansilla Alaigh, Director, External Development, Emergent Biosolutions

Hansilla Alaigh | Director, External Development | Emergent Biosolutions » speaking at Vaccine Congress USA

Ryan Alam-Garcia, International Growth, Zipline International

Mark Alderson, Director - Pneumococcal Vaccine Project Vaccine Development Global Program, Path

Mark Alderson | Director - Pneumococcal Vaccine Project Vaccine Development Global Program | Path » speaking at Vaccine Congress USA

Sally Allain, Head of JLABS Washington, DC, Johnson & Johnson Innovation

M Javad Aman, Chief Executive Officer, Integrated Biotherapeutics

M Javad Aman | Chief Executive Officer | Integrated Biotherapeutics » speaking at Vaccine Congress USA

Rama Rao Amara, Professor, Emory University

David Anderson, Chief Scientific Officer, VBI Vaccines

Steven Anderson, Director, Office Of Biostatistics And Epidemiology, U.S. Food and Drug Administration

Juan Andres, Chief Technical Operations and Quality Officer, Moderna, Inc.

Michael Angelastro, Project Officer, U.S. Department of Health & Human Services

Michael Angelastro | Project Officer | U.S. Department of Health & Human Services » speaking at Vaccine Congress USA

Phyllis Arthur, Vice President, Infectious Diseases And Diagnostics Policy, Biotechnology Innovation Organization (BIO)

Dr Jean-Christophe Audonnet, Senior Director, International R&D Governance, Coordinator Of Zapi Imi Project, Merial

Dr Jean-Christophe Audonnet | Senior Director, International R&D Governance, Coordinator Of Zapi Imi Project | Merial » speaking at Vaccine Congress USA

Stephen Auvil, Executive Vice President – Operations & Programs, Tedco

Kabeer Aziz, Principal, Adjuvant Capital

Bob Bailer, Head of Vaccines Business Unit, Q² Solutions

Jacques Banchereau, Professor, Jackson Laboratory

Dr Eileen Barry, Professor of Medicine, University of Maryland School of Medicine

Tammy Beckham, Director, Office Of Infectious Disease And Hiv/Aids Policy, NVPO, OASH, OS, HHS

Lisa Becton, Director Of Swine Health Information, National Pork Board

Lisa Becton | Director Of Swine Health Information | National Pork Board » speaking at Vaccine Congress USA

Jason Berg, Director, Project Management, PPD

Philip Bergman, Director Of Clinical Studies, V.C.A. Antech Inc

Elke Bergmann-Leitner, Chief, Immunology Core, Walter Reed Army Institute of Research

Elke Bergmann-Leitner | Chief, Immunology Core | Walter Reed Army Institute of Research » speaking at Vaccine Congress USA

Francesco Berti, Head Of Antigen Design, Preclinical Research And Development, GlaxoSmithKline

Jay Berzofsky, Branch Chief, Vaccine Branch, National Cancer Institute - NIH

Dr Prakash Bhuyan, Vice President, Clinical Development, inovio

Sandra Blome, Senior Scientist, Friedrich-Loeffler-Institut

Matthew Bottomley, Head Of Structure Based Antigen Design Laboratory, GlaxoSmithKline

Matthew Bottomley | Head Of Structure Based Antigen Design Laboratory | GlaxoSmithKline » speaking at Vaccine Congress USA

Mena Boules, Associate Medical Director, Medical Affairs, Gastroenterology, FERRING Pharmaceuticals

Mena Boules | Associate Medical Director, Medical Affairs, Gastroenterology | FERRING Pharmaceuticals » speaking at Vaccine Congress USA

Lindsay Brady, Project Management Manager, PPD

Thomas Breuer, Senior Vice President, Chief Medical Officer, GSK Vaccines

Thomas Breuer | Senior Vice President, Chief Medical Officer | GSK Vaccines » speaking at Vaccine Congress USA

Rick Bright, Deputy Assistant Secretary for Preparedness and Response & Director, BARDA

Dr Kate Broderick, Vice President, Research And Development, Inovio Pharmaceuticals

Dr Kate Broderick | Vice President, Research And Development | Inovio Pharmaceuticals » speaking at Vaccine Congress USA

Joshua Brody, Assistant Professor, Medicine, Hematology And Medical Oncology, Icahn School of Medicine at Mount Sinai

Scott Brown, Vice President, Zoetis

Scott Brown | Vice President | Zoetis » speaking at Vaccine Congress USA

George Buchman, VP, Preclinical & Process Development, Catalent Biologics | Paragon Gene Therapy

Philip Buck, Head, Us Health Outcomes And Epidemiology, Vaccines, GlaxoSmithKline

Lynlee Burton, Senior Director Of Therapeutic Expertise - Vaccines, PRA Health Sciences

Lynlee Burton | Senior Director Of Therapeutic Expertise - Vaccines | PRA Health Sciences » speaking at Vaccine Congress USA

Kim Bush, Director, Life Sciences Partnerships, Global Healthc Program, The Bill & Melinda Gates Foundation

Aude-Helene Capietto, Principal scientific Researcher, Genentech

Andrew Catchpole, Scientific And Operations Director, hVIVO

Allison Chamberlain, Acting Director, Emory Center for Public Health Preparedness and Research,, Rollins School of Public Health Emory University

Robert Chen, Scientific Director, Brighton Collaboration, a program of the Task Force for Global Health

Chloe Chepigin, Senior Associate, Avalere Health

Roman Chicz, Associate Vice President And Global Head Of External Research And Development, Sanofi Pasteur

Gwo-Yu Chuang, Co-Head And Staff Scientist Structural Bioinformatics Core Section, National Institute of Health - NIAID

Gwo-Yu Chuang | Co-Head And Staff Scientist Structural Bioinformatics Core Section | National Institute of Health - NIAID » speaking at Vaccine Congress USA

Amy Chung, Laboratory Head, Department of Microbiology and Immunology, The Peter Doherty Institute For Infection and Immunity

Amy Chung | Laboratory Head, Department of Microbiology and Immunology | The Peter Doherty Institute For Infection and Immunity » speaking at Vaccine Congress USA

Nadia Cohen, Alliance Manager, CARB-X

Timothy Cooke, Senior Vice President, NVPO

Timothy Cooke | Senior Vice President | NVPO » speaking at Vaccine Congress USA

Louise Cosby, Head of Virology, Agri-Food and Biosciences Institute

Louise Cosby | Head of Virology | Agri-Food and Biosciences Institute » speaking at Vaccine Congress USA

Dr Stephen Craven, Functional Lead, APC

Dr Stephen Craven | Functional Lead | APC » speaking at Vaccine Congress USA

Jessica Crawford, Director, VillageReach

Dr James Cummings, President, ICON Government & Public Health Solutions

Dr James Cummings | President | ICON Government & Public Health Solutions » speaking at Vaccine Congress USA

Michelle Cunningham, Business Development, Clinical Network Services

Gerard Cunningham, Operating Partner, Adjuvant Capital

Inger Damon, Director, Division Of High Consequence Pathogens And Pathology, Centers for Disease Control and Prevention

Inger Damon | Director, Division Of High Consequence Pathogens And Pathology | Centers for Disease Control and Prevention » speaking at Vaccine Congress USA

Maarten Danial, Project Leader And Organic Chemist, Intravacc

Maarten Danial | Project Leader And Organic Chemist | Intravacc » speaking at Vaccine Congress USA

Barry Datlof, Chief, Business Development And Commercialization, U.S. Army Medical Research and Development Command

Michel De Baar, Executive Director, Business Development And Licensing, Merck

Ennio De Gregorio, Lab Head Of Bio Analytics Research and Development, GlaxoSmithKline

Ennio De Gregorio | Lab Head Of Bio Analytics Research and Development | GlaxoSmithKline » speaking at Vaccine Congress USA

Jolanda De Vries, Head Tumour Immunology Department, RadboudUMC

Jolanda De Vries | Head Tumour Immunology Department | RadboudUMC » speaking at Vaccine Congress USA

Dr Michel De Wilde, Former Senior Vice President R&D Of Sanofi Pasteur & Owner, MDW Consultant LLC

Dr Michel De Wilde | Former Senior Vice President R&D Of Sanofi Pasteur & Owner | MDW Consultant LLC » speaking at Vaccine Congress USA

Cynthia Derdeyn, Professor, Emory University

Prasanna Deshpande, Deputy Managing Director, Indian Immunologicals Ltd

Madhav Dhodapkar, Professor, Emory University

Dr Francisco Diaz-Mitoma, Chief Medical Officer, VBI Vaccines

Dr Francisco Diaz-Mitoma | Chief Medical Officer | VBI Vaccines » speaking at Vaccine Congress USA

Carl Dieffenbach, Director, Division Of Aids, Niaid, NIH

Dennis Dixon, Chief Bacteriology And Mycology Branch, National Institutes of Health

David Dowling, Instructor In Pediatrics, Boston Children's Hospital

David Dowling | Instructor In Pediatrics | Boston Children's Hospital » speaking at Vaccine Congress USA

Patrick Duffy, Chief Of Pathogenesis And Immunity Section, National Institutes of Health

Patrick Duffy | Chief Of Pathogenesis And Immunity Section | National Institutes of Health » speaking at Vaccine Congress USA

Cynthia Dukes, VP, Drug Development Services and Global Head of Vaccine Center of Excellence, ICON Clinical Research

Dr Anna Durbin, Associate Professor, Johns Hopkins Bloomberg School of Public Health

Dr Marilyn Dysart, Clinical Affairs Manager, PharmaJet

Chris Earnhart, Chief Technology Officer, JPEO-CBRND

Kathryn Edwards, Pediatrics Chair And Pediatrics Professor, Vanderbilt University

Joseph Eiden, Senior Medical Advisor, FluGen Inc

Joseph Eiden | Senior Medical Advisor | FluGen Inc » speaking at Vaccine Congress USA

Andrew Eisen, Vice President Of Clinical Development, Immunomic Therapeutics

Mark Emalfarb, President And Chief Executive Officer, Dyadic International Inc

Thomas Evans, Vaccitech

Thomas Evans |  | Vaccitech » speaking at Vaccine Congress USA

Jay Evans, President And Chief Executive Officer, Inimmune

Jay Evans | President And Chief Executive Officer | Inimmune » speaking at Vaccine Congress USA

Jason Ezzelle, Chief Commercial And Government Contracts Officer, Pharm-Olam

Tony Fauci, Director, NIAID, NIH

Deshayne Fell, Assistant Professor, Epidemiology And Public Health, University of Ottawa

Carl G Figdor, Director Of The Centre For Molecular Life Sciences And Head Of The Department Of Tumour Immunology, RadboudUMC

Anthony Fiore, Associate Director, Centers for Disease Control and Prevention

Robert Fisher, Senior Advisor for CBRN and Pandemic Influenza, Office of Counterterrorism and Emerging Threats (OCET), Food and Drug Administration (FDA)

Meagan Fitzpatrick, Assistant Professor Of The Center For Vaccine Development And Global Health, University of Maryland

Meagan Fitzpatrick | Assistant Professor Of The Center For Vaccine Development And Global Health | University of Maryland » speaking at Vaccine Congress USA

Milward Francis, Head Of Global Assay, Services Vaccine R&D, Boehringer Ingelheim

Leonard Friedland, Vice President, Scientific Affairs And Public Health Vaccines, North America, GSK

Katriel Friedman, Chief Executive Officer, Charity Science Health

Katriel Friedman | Chief Executive Officer | Charity Science Health » speaking at Vaccine Congress USA

Leena Gandhi, Vice President Of Immuno Oncology Development, Eli Lilly and Company

Cyril Gay, Senior National Program Leader, A.R.S. National Programs

Dr Bruce Gellin, President, Global Immunization, Sabin Vaccine Institute

Dr Bruce Gellin | President, Global Immunization | Sabin Vaccine Institute » speaking at Vaccine Congress USA

Julie Gerberding, Executive Vice President, Communications, Global Policy, And Population Health And Chief Patient Officer, Merck

Volker Gerdts, Director And Chief Executive Officer, VIDO-InterVac

Volker Gerdts | Director And Chief Executive Officer | VIDO-InterVac » speaking at Vaccine Congress USA

Christiane Gerke, Head Of Vaccine Programs, Institut Pasteur

Marta Germano, Scientific Director Group Head Of Product Characterization, Janssen Pharmaceutical

Marta Germano | Scientific Director Group Head Of Product Characterization | Janssen Pharmaceutical » speaking at Vaccine Congress USA

Dr Brad Gessner, Vice President, Global Medical Lead For Pneumococcal Vaccines, Pfizer

Ann Ginsberg, Deputy Director, B.M.G.F.

Ann Ginsberg | Deputy Director | B.M.G.F. » speaking at Vaccine Congress USA

Dr Ann Ginsberg, Senior Technical Advisor, International Aids Vaccine Initiative

Douglas Gladue, Senior Scientist, Plum Island Animal Disease Center, USDA

Douglas Gladue | Senior Scientist, Plum Island Animal Disease Center | USDA » speaking at Vaccine Congress USA

Geoffrey Glauser, Former Supply Chain Executive, Pfizer & Merck

Gregory Glenn, President, Research And Development, Novavax

Gregory Glenn | President, Research And Development | Novavax » speaking at Vaccine Congress USA

John Goldberg, Senior Vice President Of Clinical Development, Oncorus

John Goldberg | Senior Vice President Of Clinical Development | Oncorus » speaking at Vaccine Congress USA

Jody Gould, Senior Regulatory Affairs Director, GlaxoSmithKline

Barney Graham, Deputy Director Of Vaccine Research Center, National Institute of Health - NIAID

Barney Graham | Deputy Director Of Vaccine Research Center | National Institute of Health - NIAID » speaking at Vaccine Congress USA

Sonia Gregory, Scientific Leader, GSK Vaccines

Dr Beth Ann Griswold-Coller, Executive Director, Vaccines Clinical Research,, Merck Research Laboratories

William Gruber, Senior Vice President, Pfizer Vaccine Clinical Research, Pfizer

William Gruber | Senior Vice President, Pfizer Vaccine Clinical Research | Pfizer » speaking at Vaccine Congress USA

Dr Farshad Guirakhoo, CSO, GeoVax, Inc.

Dr Farshad Guirakhoo | CSO | GeoVax, Inc. » speaking at Vaccine Congress USA

Vikas Gupta, Director Of Clinical Strategy, Becton Dickinson

Sanjay Gurunathan, VP Global Clinical Development, Sanofi Pasteur

Sanjay Gurunathan | VP Global Clinical Development | Sanofi Pasteur » speaking at Vaccine Congress USA

Scott Halstead, Adjunct Professor, Department Of Preventive Medicine And Biometrics, Uniformed Services University

Scott Halstead | Adjunct Professor, Department Of Preventive Medicine And Biometrics | Uniformed Services University » speaking at Vaccine Congress USA

Ivana Haluskova Balter, Medical and Scientific Consultant, French Society of Immunology

Kelly Hamblin, Program Officer, The Bill & Melinda Gates Foundation

Melinda Hamer, Chief, Clinical Trials Center, Walter Reed Army Institute Of Research

Melinda Hamer | Chief, Clinical Trials Center | Walter Reed Army Institute Of Research » speaking at Vaccine Congress USA

Sean Hart, Chief Executive Officer, LumaCyte

Sean Hart | Chief Executive Officer | LumaCyte » speaking at Vaccine Congress USA

Kathryn Hashey, Scientist, GSK

Kathryn Hashey | Scientist | GSK » speaking at Vaccine Congress USA

Teresa Hauguel, Program Officer, National Institute of Health - NIAID

Samantha Hawgood, Director, GSK Vaccines

Samantha Hawgood | Director | GSK Vaccines » speaking at Vaccine Congress USA

Daria Hazuda, Vice President, Therapeutic Area, Head Of Infectious Disease And Chief Scientific Officer, Merck Research Laboratories

Daria Hazuda | Vice President, Therapeutic Area, Head Of Infectious Disease And Chief Scientific Officer | Merck Research Laboratories » speaking at Vaccine Congress USA

Peter Heegaard, Professor, National Veterinary Institute Technical University of Denmark

Daniel Henderson, Chief Executive Officer, Verndari

Daniel Henderson | Chief Executive Officer | Verndari » speaking at Vaccine Congress USA

Dr Jenny Hendriks, Head Biomarkers, Janssen Vaccines & Prevention B.V.

Dr Jenny Hendriks | Head Biomarkers | Janssen Vaccines & Prevention B.V. » speaking at Vaccine Congress USA

Susan Hensley, Senior Director, Regular Operations, Compliance And Regular Affairs, Takeda

Nathaniel Hentz, Scientific Market Development Director, Artel, LLC

Matthew Hepburn, Program Manager, D.A.R.P.A.

Matthew Hepburn | Program Manager | D.A.R.P.A. » speaking at Vaccine Congress USA

Dr Gray Heppner, Chief Medical Officer And Managing Partner, Crozet BioPharma LLC

Dr Gray Heppner | Chief Medical Officer And Managing Partner | Crozet BioPharma LLC » speaking at Vaccine Congress USA

Annett Hessel, Principal Scientist, Pfizer

Elizabeth Higgs, Global Health Science Advisor, National Institute of Health - NIAID

Elizabeth Higgs | Global Health Science Advisor | National Institute of Health - NIAID » speaking at Vaccine Congress USA

Andy Hillier, Medical Lead Dermatology And Allergy, Veterinary Specialty Operations, Zoetis

Dr Karin Hoelzer, Senior Officer, The Pew Charitable Trusts

Stephen Hoffman, Chief Executive And Scientific Officer, Sanaria

Elizabeth Hohmann, Infectious Disease, Massachusetts General Hospital

Elizabeth Hohmann | Infectious Disease | Massachusetts General Hospital » speaking at Vaccine Congress USA

Rosalind Hollingsworth, Avp Global Medical Expert Lead, Influenza, Gma, Sanofi Pasteur

Dr Peter Hotez, Dean, National School Of Tropical Medicine, Director, Texas Children's Hospital Center, Baylor College of Medicine

Richard Hughes, Managing Director, Avalere Health Llc

Andrew Ishizuka, CSO, Avidea Technologies

Dr Stephen Albert Johnston, Director, Biodesign Institute at Arizona State University

Dr Stephen Albert Johnston | Director | Biodesign Institute at Arizona State University » speaking at Vaccine Congress USA

Robert Juba, Vice President Of Biological Manufacturing And Clinical Supply Management, inovio

Laura Kahn, Co-Founder, One Health Initiative

Nicole Kallewaard, Associate Director, Microbial Sciences, AstraZeneca

Chil-Yong Kang, Professor, Western University

Dr Cheryl Keech, Chief Medical Officer And Executive Vice President Of Clinical Research, ILiAD Biotechnologies, LLC

Dr Cheryl Keech | Chief Medical Officer And Executive Vice President Of Clinical Research | ILiAD Biotechnologies, LLC » speaking at Vaccine Congress USA

Marcus Kehrli, Director, Agricultural Research Service U.S.D.A.

Arifa Khan, Supervisory Microbiologist, FDA

Arifa Khan | Supervisory Microbiologist | FDA » speaking at Vaccine Congress USA

Alena Khromava, Pharmacoepi Head, Sanofi Pasteur

Maura Kibbey, Senior Scientific Fellow, U.S.P.

Maura Kibbey | Senior Scientific Fellow | U.S.P. » speaking at Vaccine Congress USA

Douglas E Kiehl, Research Advisor, Bioproduct, Research And Development, Eli Lilly and Company

Kevin Killeen, Chief Scientific Officer, Matrivax R & D Corp

Kevin Killeen | Chief Scientific Officer | Matrivax R & D Corp » speaking at Vaccine Congress USA

Joseph Kim, Chief Executive Officer, Inovio Pharmaceuticals

Joseph Kim | Chief Executive Officer | Inovio Pharmaceuticals » speaking at Vaccine Congress USA

Dr Elizabeth Klemm, Project Officer, Wellcome Trust

Dr Elizabeth Klemm | Project Officer | Wellcome Trust » speaking at Vaccine Congress USA

Charles Kline, Distinguished Scientist, Merck

Dr Alexander Koglin, Founder, NTx

Dr Alexander Kort, Senior Vice President Corporate Development, Themis Bioscience

Dr Alexander Kort | Senior Vice President Corporate Development | Themis Bioscience » speaking at Vaccine Congress USA

Dr Richard Koup, Deputy Director, Vaccine Research Center, Chief, Immunology Laboratory And Immunology Section, National Institute of Health - NIAID

Philip Krause, Deputy Director, U.S. Food and Drug Administration

Philip Krause | Deputy Director | U.S. Food and Drug Administration » speaking at Vaccine Congress USA

Frederic Krohn, Director Business Development, CureVac

Frederic Krohn | Director Business Development | CureVac » speaking at Vaccine Congress USA

Andreas Kuhn, Vice President, BioNTech Ag

Mahesh Kumar, Senior Vice President, Global Biologics Research, Zoetis

Mahesh Kumar | Senior Vice President, Global Biologics Research | Zoetis » speaking at Vaccine Congress USA

Arvind Kumar, Lead, Discovery Biology Research (Bacteriology And Parasitology) Erl, Elanco Animal Health

Arvind Kumar | Lead, Discovery Biology Research (Bacteriology And Parasitology) Erl | Elanco Animal Health » speaking at Vaccine Congress USA

Peter Kwong, Chief, Structural Biology Section, National Institute of Health - NIAID

Tom Lake, Senior Vice President, Vaccine Development Alliances, Vaxxas

Dr Patricia Lawman, Chief Executive Officer, Morphogenesis I.N.C.

Sherry Layton, Chief Scientific Officer, Vetanco Sa

Marie-Liesse Le Corfec, Global Portfolio Marketing Head, Ps, B.D. Pharmaceuticals Systems

Dr Wolfgang Leitner, Chief, Innate Immunity Section, National Institute of Health - NIAID

Dr Stéphane Lemiere, Global Avian Technical Director, Boehringer-Ingelheim

Dr Ofer Levy, Director, Precision Vaccines Program, Boston Children's Hospital Harvard Medical School

Nick Lewis, Consultant, One Health Ventures Ltd

Thomas Liechti, Project Lead, NIH

Thomas Liechti | Project Lead | NIH » speaking at Vaccine Congress USA

Hyun Lillehoj, Animal Biosciences And Biotechnology Laboratory, Agricultural Research Service U.S.D.A.

Eric Lombardini, Director, US Army Medical Directorate of the Armed Forces Research Institute of Medical Sciences (USAMD-AFRIMS)

Eric Lombardini | Director | US Army Medical Directorate of the Armed Forces Research Institute of Medical Sciences (USAMD-AFRIMS) » speaking at Vaccine Congress USA

Angela Luttick, EVP, Business Development, 360biolabs Pty Ltd

Angela Luttick | EVP, Business Development | 360biolabs Pty Ltd » speaking at Vaccine Congress USA

Rebecca Lynch, Assistant Professor, The George Washington University

Raina Macintyre, Professor Of Global Biosecurity And Nhmrc Principal Research Fellow, University of New South Wales

Helen Huihua Mao, Senior Vice President, CanSino Biologics Inc.

Helen Huihua Mao | Senior Vice President | CanSino Biologics Inc. » speaking at Vaccine Congress USA

Dr John Markels, President, Merck Vaccines

Mary Marovich, Director Of Vaccine Research Program, NIAID, NIH

Hilary Marston, Medical Officer And Policy Advisor, National Institutes of Health

Hilary Marston | Medical Officer And Policy Advisor | National Institutes of Health » speaking at Vaccine Congress USA

Tyler Martin, Chief Executive Officer, Adjuvance Technologies

Anton McCaffrey, Senior Director of Emerging Science and Innovation, TriLink BioTechnologies

Karen Mccarthy, Executive Director, Vaccines, PPD

Karen Mccarthy | Executive Director, Vaccines | PPD » speaking at Vaccine Congress USA

Will McCauley, Director, Veterinary Biologics, Animal Health Institute

Bill Mcgillian, Associate Engineering Director, Merck

Bill Mcgillian | Associate Engineering Director | Merck » speaking at Vaccine Congress USA

Michael McNeil, Microbiology Researcher, Centers for Disease Control and Prevention

Duccio Medini, Senior Director, Head Of Data Science And Clinical Systems, GlaxoSmithKline

Duccio Medini | Senior Director, Head Of Data Science And Clinical Systems | GlaxoSmithKline » speaking at Vaccine Congress USA

Dr Matthew Memoli, Director, NIAID-NIH

Gisele Miranda, Advisor, Fiocruz

Elizabeth Mittendorf, Director, Breast Immuno-Oncology Program, Co-Director, Breast Cancer Clinical Research Program, Dana Farber Cancer Institute

Emanuele Montomoli, Professor In Public Health University Of Siena And Chief Scientific Officer, VisMederi

Pedro Moro, Epidemiologist, Centers for Disease Control and Prevention

Dr Alex Morrow, Head Of The Secretariat To The International Research Consortium, STAR-IDAZ

Dr Alex Morrow | Head Of The Secretariat To The International Research Consortium | STAR-IDAZ » speaking at Vaccine Congress USA

Dr Michael Mowatt, Director, Technology Transfer And Intellectual Property Office, National Institute of Health - NIAID

Flor Munoz-Rivas, Assistant Professor Of Pediatrics-Infectious Disease, Baylor College of Medicine

Flor Munoz-Rivas | Assistant Professor Of Pediatrics-Infectious Disease | Baylor College of Medicine » speaking at Vaccine Congress USA

Jean-Jacques Muyembe-Tamfum, General Director, Democratic Republic of Congo

Jean-Jacques Muyembe-Tamfum | General Director | Democratic Republic of Congo » speaking at Vaccine Congress USA

Dr Gary Nabel, CSO, Sanofi

Dr Gary Nabel | CSO | Sanofi » speaking at Vaccine Congress USA

Venugopal Nair, Head, The Pirbright Institute

Venugopal Nair | Head | The Pirbright Institute » speaking at Vaccine Congress USA

Helder Nakaya, Associate Professor, School of Pharmaceutical Sciences, University Of Sao Paulo

Pierguiseppe Nestola, Global Vaccine Technology Consultant, Sartorius Stedim Biotech

Dr Andreas Neubert, CSO, IDT Biologika

Kathy Neuzil, Director, Center For Vaccine Development, University of Maryland School of Medicine

Kathy Neuzil | Director, Center For Vaccine Development | University of Maryland School of Medicine » speaking at Vaccine Congress USA

Fernando Noriega, Head Of Clinical LatAm and SHPIL (India), Sanofi Pasteur

Ruslan Novosiadly, Oncology Translational Medicine Team Lead, Bristol Myers Squibb

Kate O'Brien, Director, World Health Organisation

Kate O'Brien | Director | World Health Organisation » speaking at Vaccine Congress USA

Derek O'Hagan, Senior Advisor In R&D, GSK Vaccines

Dr Saad Omer, William H. Foege Professor Of Global Health Professor Of Epidemiology And Pediatrics, Emory University - School of Medicine

Prof Ab Osterhaus, Director, Research Center For Emerging Infections And Zoonoses (Riz), University of Veterinary Medicine Hannover

Dr Inna Ovsyannikova, Professor Of Medicine, Mayo Foundation For Medical Education and Research

Rolando Pajon, Director, Moderna Therapeutics

Rolando Pajon | Director | Moderna Therapeutics » speaking at Vaccine Congress USA

Dr Peter Palese, Professor And Chair Microbiology, Mount Sinai School of Medicine

Dr Peter Palese | Professor And Chair Microbiology | Mount Sinai School of Medicine » speaking at Vaccine Congress USA

Karolina Palucka, Professor, The Jackson Laboratory for Genomic Medicine

Lori Panther, Sr. Director, Clinical Development, Infectious Diseases, Moderna Therapeutics

Norbert Pardi, Assistant Professor, University of Pennsylvania

Jee Yong Park, Project Manager, Oie World Organisation For Animal Health

John Parrish-Sprowl, Director, Global Health Communication Center Professor, Communication Studies, Indiana University Purdue University Indianapolis

Richard Pelt, Director, Vaccines Cmc Regulatory Affairs, Pfizer

Richard Pelt | Director, Vaccines Cmc Regulatory Affairs | Pfizer » speaking at Vaccine Congress USA

George E Peoples, Chief Executive Officer, Cancer Insight

Dr Nikolai Petrovsky, Chairman, Vaxine Pty.

Benjamin Petsch, Senior Director Infectious Diseases Research, CureVac AG

Louis Picker, Professor, Oregon Health & Science University

Robert Pierce, CSO, Sensei Bio

Robert Pierce | CSO | Sensei Bio » speaking at Vaccine Congress USA

Amy Pisani, Executive Director, Vaccinate Your Family

Stanley Plotkin, Emeritus Professor, University of Pennsylvania School Of Medicine

Stanley Plotkin | Emeritus Professor | University of Pennsylvania School Of Medicine » speaking at Vaccine Congress USA

Gregory Poland, Director Of Mayo Vaccine Research Group, Mayo Clinic

Ultan Power, Professor Of Molecular Virology, Wellcome Wolfson Institute For Experimental Medicine, Queen's University Belfast

Ultan Power | Professor Of Molecular Virology, Wellcome Wolfson Institute For Experimental Medicine | Queen's University Belfast » speaking at Vaccine Congress USA

Chelsea Pratt, Biopharma Market Development Manager, Bio-Rad Laboratories

Trina Racine, Cordonnateur Scientifique, Centre de Recherche en Infectiologie, Centre Hospitalier Universitaire De Quebec

Trina Racine | Cordonnateur Scientifique, Centre de Recherche en Infectiologie | Centre Hospitalier Universitaire De Quebec » speaking at Vaccine Congress USA

Paul Radspinner, Chief Executive Officer, FluGen Inc

Paul Radspinner | Chief Executive Officer | FluGen Inc » speaking at Vaccine Congress USA

Milan Raska, prof., Dept. of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc

Dr Gs Reddy, Senior Vice President, Brilliant BioPharma Ltd

Dr Dirk Redlich, Vice President Of Strategy And Operations Leader, Janssen Pharmaceutical

Dr Dirk Redlich | Vice President Of Strategy And Operations Leader | Janssen Pharmaceutical » speaking at Vaccine Congress USA

Josh Reece, Director Of Product Development, Emergent Biosolutions

Josh Reece | Director Of Product Development | Emergent Biosolutions » speaking at Vaccine Congress USA

Steven Reed, Scientific Advisory and Executive Board Member, Curevo Vaccine

Sabrina Restrepo, Director, Global Vaccines Technical Operations, Merck

Jeff Roberts, Associate Director For Scientific Affairs, FDA

Harriet Robinson, CSO, GeoVax, Inc.

Max Rossetto, General Manager Business Development, Luina Bio

Max Rossetto | General Manager Business Development | Luina Bio » speaking at Vaccine Congress USA

Nadine Rouphael, Associate Professor Of Medicine, Emory University

Nadine Rouphael | Associate Professor Of Medicine | Emory University » speaking at Vaccine Congress USA

Andriy Rozstalnyy, Animal Production And Health Officer, F.A.O

Andriy Rozstalnyy | Animal Production And Health Officer | F.A.O » speaking at Vaccine Congress USA

David Sack, Professor, Johns Hopkins Bloomberg School of Public Health

Dr Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Vaccines & Prevention B.V.

Dr Jerald Sadoff | Senior Advisor Vaccine Development | Janssen Vaccines & Prevention B.V. » speaking at Vaccine Congress USA

Dr Sushant Sahastrabuddhe, Director, Enteric Fever, International Vaccine Institute

Daniel Salmon, Director, Institute For Vaccine Safety, Johns Hopkins Bloomberg School of Public Health

Dr Niranjan Sardesai, President And Chief Executive Officer, Geneos Therapeutics

Dr Niranjan Sardesai | President And Chief Executive Officer | Geneos Therapeutics » speaking at Vaccine Congress USA

Souleymane Sawadogo, General Manager, Global Health, Parsyl

Souleymane Sawadogo | General Manager, Global Health | Parsyl » speaking at Vaccine Congress USA

Mark Schleiss, Department Of Pediatrics Professor, University of Minnesota

Emmett Schmidt, Associate Vice President, Clinical Research, Oncology, Merck Research Laboratories

Holly Seale, S Lecturer, University of New South Wales

Pamela Sears, Vice President Clinical Science, Merck

Pamela Sears | Vice President Clinical Science | Merck » speaking at Vaccine Congress USA

Shite Sebastian, Vice President, Affinivax

Shite Sebastian | Vice President | Affinivax » speaking at Vaccine Congress USA

Darin Seehafer, Director Of Therapeutic Expertise Vaccines, PRA Health Sciences

Nathan Segall, Medical Director, Clinical Research Atlanta

Jesse Sevcik, Director, Elanco Animal Health

Jesse Sevcik | Director | Elanco Animal Health » speaking at Vaccine Congress USA

Liang Shang, Senior Scientist, Merck

Albert Shaw, Professor Of Medicine (Infectious Diseases), Yale University

Albert Shaw | Professor Of Medicine (Infectious Diseases) | Yale University » speaking at Vaccine Congress USA

Jacqueline Shea, Chief Operating Offer And Executive Vice President, Inovio Pharmaceuticals, Inc

Daniel A Shelly, Director Global Business Development And Strategic Partnerships, Essential Medicines, PATH

Lisa Shelton, Associate Director Of Operations, Curevo Vaccine

Lisa Shelton | Associate Director Of Operations | Curevo Vaccine » speaking at Vaccine Congress USA

Angela Shen, ScD, MPH CAPT (Ret) US Public Health Service, Principal,, Llama Public Health Consulting LLC

Nirav Sheth, Vice President, Commercial Development, MicroMedicine

Pei-Yong Shi, Kempner Professor Of Human Genetics, University of Texas Medical Branch

Pei-Yong Shi | Kempner Professor Of Human Genetics | University of Texas Medical Branch » speaking at Vaccine Congress USA

Lora Shimp, Senior Technical Officer - Immunization, John Snow Inc

Dr Vivek Shinde, Vice President, Clinical Development Lead, Older Adult Influenza And Rsv Vaccines, Novavax

George Siber, Chief Scientific Officer Of Clearpath Vaccines And Scientific Advisory Board Of Genocea, ClearPath Vaccines

George Siber | Chief Scientific Officer Of Clearpath Vaccines And Scientific Advisory Board Of Genocea | ClearPath Vaccines » speaking at Vaccine Congress USA

Raphael Simon, Senior Director, Pfizer

Raphael Simon | Senior Director | Pfizer » speaking at Vaccine Congress USA

Dr Will Singleterry, Director Of Business Development, IsoPlexis

Dr Will Singleterry | Director Of Business Development | IsoPlexis » speaking at Vaccine Congress USA

William Smith, Chief Executive Officer, Alliance for Multispecialty Research LLC

William Smith | Chief Executive Officer | Alliance for Multispecialty Research LLC » speaking at Vaccine Congress USA

Bruno Speder, Head Of Clinical Regulatory Affairs, SGS Life Sciences

Bruno Speder | Head Of Clinical Regulatory Affairs | SGS Life Sciences » speaking at Vaccine Congress USA

Dr Julia Spencer, Associate Vice President, Global Vaccine Public Policy, Partnerships, MSD

Hanno Steen, Director of the Proteomics Center, Associate Professor of Pathology, Harvard Medical School

Jens-Ulrich Stegmann, Vice President, Head Clinical Safety And Pharmacovigilance Gsk Vaccines And Eu Qppv, Viiv Healthcare, G.S.K Biologicals

Kathryn Stephenson, Assistant Medicine Professor, Harvard Medical School

Dr Koert Stittelaar, General Manager Viroclinics Xplore, Viroclinics Biosciences B.V.

Dr Koert Stittelaar | General Manager Viroclinics Xplore | Viroclinics Biosciences B.V. » speaking at Vaccine Congress USA

Paul Stoffels, Chief Scientific Officer, Johnson & Johnson

Paul Stoffels | Chief Scientific Officer | Johnson & Johnson » speaking at Vaccine Congress USA

Walter Straus, Associate Vice President, Therapeutic Area Head, Clinical Safety And Risk Management, Merck Research Laboratories

Ken Stuart, Founder, Center For Infectious Disease Research

Ken Stuart | Founder | Center For Infectious Disease Research » speaking at Vaccine Congress USA

Terrence Stull, SVP Research, Phoenix Childrens Hospital

Terrence Stull | SVP Research | Phoenix Childrens Hospital » speaking at Vaccine Congress USA

Scott Sugden, Senior Principal Scientist, Caprion Biosciences

Scott Sugden | Senior Principal Scientist | Caprion Biosciences » speaking at Vaccine Congress USA

Lena H Sun, National Reporter, The Washington Post Company

Marulasiddappa Suresh, John E. Butler Professor Of Comparative And Mucosal Immunology, Director, Comparative Biomedical Sciences Graduate Program, University of Wisconsin-Madison

Marulasiddappa Suresh | John E. Butler Professor Of Comparative And Mucosal Immunology, Director, Comparative Biomedical Sciences Graduate Program | University of Wisconsin-Madison » speaking at Vaccine Congress USA

Todd Suscovich, Chief Technical Officer, Seromyx

Todd Suscovich | Chief Technical Officer | Seromyx » speaking at Vaccine Congress USA

Kathryn Sykes, Vice President Research And Product Development, Calviri Inc

Dr Adel Talaat, Professor Of Microbiology, University of Wisconsin-Madison

Dr Adel Talaat | Professor Of Microbiology | University of Wisconsin-Madison » speaking at Vaccine Congress USA

Julia Tarasenko, Senior Director, US Strategic Account Team, Marken

Andi Tate, Director, PPD

Graham Taylor, Senior Lecturer In Tumour Immunology, University of Birmingham

Ronen Tchelet, Chief Scientific Officer, Dyadic International Inc

Col Deydre Teyhen, Dtp, Phd, Ocs, Commander, Walter Reed Army Institute Of Research

Douglas Thamm, Professor, Oncology, Colorado State University

Douglas Thamm | Professor, Oncology | Colorado State University » speaking at Vaccine Congress USA

Stephen Thomas, Chief, Division Of Infectious Diseases, New York Upstate Medical University

Adam Thompson, Executive Director and Co-founder, eHealth Africa

Thomas Tillett, Chief Executive Officer And President, MBF Therapeutics

Thomas Tillett | Chief Executive Officer And President | MBF Therapeutics » speaking at Vaccine Congress USA

Gregory Tobin, Chief Executive Officer, Biological Mimetics, Inc.

Gregory Tobin | Chief Executive Officer | Biological Mimetics, Inc. » speaking at Vaccine Congress USA

Dr Frank Tomaka, Senior Director, Clinical Lead HIV/STI Vaccines, Janssen Vaccines & Prevention B.V.

Dr Frank Tomaka | Senior Director, Clinical Lead HIV/STI Vaccines | Janssen Vaccines & Prevention B.V. » speaking at Vaccine Congress USA

Alberto E Tozzi, Chief Innovation Officer & Research Area Coordinator, Ospedale Pediatrico Bambino Gesu

Dr Sean Tucker, Chief Scientific Officer And Vice President Research, Vaxart

Hayato Urabe, Senior Director of Investment, Global Health Innovative Technology Fund

Robert Van Den Berg, Director, GlaxoSmithKline Vaccines

Robert Van Den Berg | Director | GlaxoSmithKline Vaccines » speaking at Vaccine Congress USA

Michael Van Der Horst, Wacker Biotech Gmbh

Aernout Van Haarst, Director Of Scientific Affairs, Celerion

Mark Van Ooij, Scientific Director, Per.C6 Technical Lead And Head Of Platform Innovation And Implementation, Janssen

John Vasilakos, Senior Research Immunologist & Bus. Dir. of TLRs, 3M Drug Delivery Systems Division

Eric Vela, Associate Director Of Upstream Development, Ology Bioservices, Inc.

Eric Vela | Associate Director Of Upstream Development | Ology Bioservices, Inc. » speaking at Vaccine Congress USA

An Vermeersch, Vice President And Head Of Global Governmental Affairs And Global Health, GlaxoSmithKline

An Vermeersch | Vice President And Head Of Global Governmental Affairs And Global Health | GlaxoSmithKline » speaking at Vaccine Congress USA

Tammie Wahaus, Chief Financial Officer, TVAX Biomedical Inc.

Sebastien Walpen, Chief Executive Officer, Ceidos

Sebastien Walpen | Chief Executive Officer | Ceidos » speaking at Vaccine Congress USA

Dr Brian Ward, Medical Officer, Medicago

Kelly Lyn Warfield, Vice President Of Vaccines, Anti-Infectives, Research And Development, Emergent Biosolutions

James Wassil, Chief Operating Officer, SutroVax, Inc

Mike Watson, Snr Director of Business Development, Nucleus Network

Heinz Weidenthaler, VP Clinical Strategy Infectious Diseases, Bavarian Nordic

David Weiner, Professor And Ww Smith Chair In Cancer Research Director Wistar Vaccine Center And Executive Vice President, The Wistar Institute

David Weiner | Professor And Ww Smith Chair In Cancer Research Director Wistar Vaccine Center And Executive Vice President | The Wistar Institute » speaking at Vaccine Congress USA

Richard Welch, Vice President Of Process Of Analytical Development, Emergent Biosolutions

Richard Welch | Vice President Of Process Of Analytical Development | Emergent Biosolutions » speaking at Vaccine Congress USA

Deborah Whitmer, Chief Of Staff, U.S. Army Medical Research and Development Command

Adrian Wildfire, Scientific Director - Infectious Diseases And Viral Infection Unit, SGS Life Science Services

Todd Wilson, Director, Early Clinical Development, GSK Vaccines

Todd Wilson | Director, Early Clinical Development | GSK Vaccines » speaking at Vaccine Congress USA

Mark Wissel, Director, Viracor Eurofins

Mark Wissel | Director | Viracor Eurofins » speaking at Vaccine Congress USA

Daniel Wolfe, Project Officer, Biomedical Advanced Research And Development Authority

Daniel Wolfe | Project Officer | Biomedical Advanced Research And Development Authority » speaking at Vaccine Congress USA

Larry Wolfraim, Vaccine Product Development Project Officer, Biodefense Vaccines & Other Biolgl Product Dvpmt Sect (HNM5C2)

Stephen Wolpe, Entrepreneur-In-Residence, BioHealth Innovation

Stephen Wolpe | Entrepreneur-In-Residence | BioHealth Innovation » speaking at Vaccine Congress USA

Lauren V Wood Md, Chief Medical Officer, P.D.S. Biotechnology Corp

Christopher Woods, Professor And Chief Infectious Diseases Division, Duke University

Stephen Wu, Director Global Vaccines Collaborations, Elanco

John Wyckoff, Director, Colorado State University

John Wyckoff | Director | Colorado State University » speaking at Vaccine Congress USA

Chris Yallop, Chief Operations And Scientific Officer, Batavia Biosciences

Chris Yallop | Chief Operations And Scientific Officer | Batavia Biosciences » speaking at Vaccine Congress USA

Inci Yildirim, Assistant Professor, Division of Pediatric Infectious Diseases, Emory University School of Medicine, Department of Epidemiology, Rollins School of Public Health Emory University

Inci Yildirim | Assistant Professor, Division of Pediatric Infectious Diseases, Emory University School of Medicine, Department of Epidemiology | Rollins School of Public Health Emory University » speaking at Vaccine Congress USA

Earl Zablackis, Director And Principal Scientist, Sanofi Pasteur

Darin Zehrung, Global Program Leader, Medical Devices And Health Technologies, Path

Yenlik Zheteyeva, Director, Clinical Safety And Risk Management, Merck Research Laboratories

Xianzhi Zhou, Bioassay Manager, GSK Vaccines

Xianzhi Zhou | Bioassay Manager | GSK Vaccines » speaking at Vaccine Congress USA